arsenic has been researched along with Di Guglielmo Disease in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beneytout, JL; Bertrand, J; Ghezali, L; Leger, DY; Liagre, B | 1 |
Grzanka, A; Grzanka, D; Izdebska, M; Ostrowski, M; ZuryĆ, A | 1 |
Cheng, Z; Li, L; Liang, W; Pan, L; Yan, X; Yang, N | 1 |
Bonati, A; Costanzo, A; Levrero, M; Lunghi, P | 1 |
Lin, M; Wang, Z; Zhang, D | 1 |
Hunt, CA; Weiss, TL; Wu-Pong, S | 1 |
Aggarwal, BB; Estey, EH; Estrov, Z; Harris, D; Kantarjian, HM; Manna, SK; Talpaz, M; Van, Q | 1 |
Caldarera, CM; Flamigni, F; Guarnieri, C; Marmiroli, S | 1 |
8 other study(ies) available for arsenic and Di Guglielmo Disease
Article | Year |
---|---|
Cyclooxygenase-2 positively regulates Akt signalling and enhances survival of erythroleukemia cells exposed to anticancer agents.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Casein Kinase II; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Etoposide; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Erythroblastic, Acute; Oxides; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; RNA, Small Interfering; Signal Transduction; Staurosporine | 2013 |
Effect of arsenic trioxide (Trisenox) on actin organization in K-562 erythroleukemia cells.
Topics: Actins; Apoptosis; Arsenic Trioxide; Arsenicals; Cytoplasm; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Leukemia, Erythroblastic, Acute; Microscopy, Fluorescence; Oxides; Tumor Cells, Cultured | 2009 |
Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
Topics: Adenoviridae; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Survival; Cytarabine; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Leukemic; Green Fluorescent Proteins; HEK293 Cells; Humans; Immunoblotting; K562 Cells; Leukemia, Erythroblastic, Acute; Oxides; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; PTEN Phosphohydrolase; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Transcription Factor RelA; Transfection | 2012 |
Treatment with arsenic trioxide (ATO) and MEK1 inhibitor activates the p73-p53AIP1 apoptotic pathway in leukemia cells.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Arsenic Trioxide; Arsenicals; Benzamides; DNA-Binding Proteins; Enzyme Inhibitors; Flavonoids; Genes, Tumor Suppressor; Humans; In Vitro Techniques; K562 Cells; Leukemia, Erythroblastic, Acute; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase Kinases; Nuclear Proteins; Oxides; Proteins; Tumor Protein p73; Tumor Suppressor Proteins | 2004 |
Preparation of orpiment nanoparticles and their cytotoxic effect on cultured leukemia K562 cells.
Topics: Antineoplastic Agents; Apoptosis; Arsenicals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Inhibitory Concentration 50; K562 Cells; Leukemia, Erythroblastic, Acute; Microscopy, Electron, Transmission; Nanoparticles; Nanotechnology; Particle Size; Spectrophotometry; Sulfides; Time Factors | 2007 |
Calcium dependent cellular uptake of a c-myc antisense oligonucleotide.
Topics: Animals; Arsenicals; Base Sequence; Biological Transport; Calcium; Cell Line; Chloroquine; Deoxyglucose; Genes, myc; Humans; Kinetics; Leukemia, Erythroblastic, Acute; Macrophages; Molecular Sequence Data; Monensin; Oligonucleotides, Antisense; Proto-Oncogene Mas; Trypsin; Tumor Cells, Cultured | 1994 |
Phenylarsine oxide blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells.
Topics: Acute Disease; Antineoplastic Agents; Apoptosis; Arsenicals; Caspase 3; Caspase Inhibitors; Cell Division; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Gene Expression Regulation, Leukemic; Humans; Interleukin-1; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid; Neoplasm Proteins; Neoplastic Stem Cells; NF-kappa B; Protein Tyrosine Phosphatases; Transcription, Genetic; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1999 |
Effect of sodium arsenite on the induction and turnover of ornithine decarboxylase activity in erythroleukemia cells.
Topics: Animals; Arsenic; Arsenites; Carmustine; Cell Line; Cycloheximide; Enzyme Induction; Friend murine leukemia virus; Half-Life; Leukemia, Erythroblastic, Acute; Mice; Ornithine Decarboxylase; Oxidation-Reduction; Peroxides; Sodium Compounds; tert-Butylhydroperoxide | 1989 |